Showing results (1-10 of 290) with videos related to
Sort By:
Pageof 29
Seminars in Oncology Nursing|January 29, 2008
EGFR mutations and EGFR tyrosine kinase inhibition in non-small cell lung cancerVincent A MillerSeminars in Oncology|February 14, 2006
Optimizing therapy in previously treated non-small cell lung cancerVincent A MillerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directionsWilliam Pao, Vincent A MillerOncology (Williston Park, N.Y.)|May 20, 2010
Use of erlotinib or gefitinib as initial therapy in advanced NSCLCGeoffrey R Oxnard, Vincent A MillerClinical Lung Cancer|December 12, 2003
Antitumor activity and tolerability of gefitinib in patients with non-small-cell lung cancer treated in an expanded access programNeelam T Shah, Vincent A MillerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Vascular endothelial growth factor trap in non small cell lung cancerGregory J Riely, Vincent A MillerSeminars in Oncology|July 1, 2005
Advances in cytotoxic chemotherapy for the treatment of metastatic or recurrent non-small cell lung cancerDaniel T Milton, Vincent A MillerTranslational Lung Cancer Research|December 4, 2018
Approach to evaluating tumor mutational burden in routine clinical practiceJohn Truesdell, Vincent A Miller, David FabrizioSeminars in Cancer Biology|February 6, 2004
'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC)William Pao, Vincent A Miller, Mark G KrisJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunitiesVincent A Miller, Fred R Hirsch, David H JohnsonPageof 29